N
Google TrendPOSICIONES DE ATLÉTICO DE MADRID CONTRA MANCHESTER UNITED (5000+) — Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:posiciones de atlético de madrid contra manchester united5000+devils vs red wings2000+lioness season 35000+luis díaz200+halle berry child custody hearing200+lamine yamal5000+thélyson orélien500+abdulrahman alfozan500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "IDH1/2 Somatic Mutations:" (30 stories)

Top Headline Story

Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markers
Lead StoryNatureworld
Jun 30

Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markers

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9SeUMtWVNXNFd6MTlUamZDTWlTWUZmelE2UXZNRlVCUHNUNkxyQkZuWFlGOEJJZ0RrZXFESnhBVHdXVGhhM2tFem4walBEMXdhazlPZU1yMm5Tam5KWWFZ?oc=5" target="_blank">Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markers</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
5000+18m ago

posiciones de atlético de madrid contra manchester united

Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League

Filter stories
2000+18m ago

devils vs red wings

Devils at Red Wings projected lineups

Filter stories
5000+18m ago

lioness season 3

Thank Zoe Saldaña for ‘Lioness’ Season 3’s Perfect Cliff-Hanger

Filter stories
200+28m ago

luis díaz

Max Eberl knows Luis Díaz will start scoring again for Bayern Munich

Filter stories

Search Results for "IDH1/2 Somatic Mutations:"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
IDH1/2 Somatic Mutations: A Treatable Inflammatory Condition
Medscapegeneral

IDH1/2 Somatic Mutations: A Treatable Inflammatory Condition

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOTkhMMG5iZ1ZDSWx1ZmFaUUhscTg4T25LRVhEdmd0Vk1GRWx2cGFibkprRHdLOHJ4cXRKbldPdkY4LXBucnF3NWpFeUJNUzlTdmxaZDBUdkF6ODNDUkNKa0lkRU5aSXVKa0NEc2Z5Sjhjb240c09fSUU1S1pOa3pBVnQ4Mkc2VTB5TXNBUGxSeVdrSTNNRHZFVjV0S0VKR1JVQlJHcFJadEEyd1ZMUTFV?oc=5" target="_blank">IDH1/2 Somatic Mutations: A Treatable Inflammatory Condition</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Somatic Mutations of IDH1 and IDH2 in the Leukemic Transformation of Myeloproliferative Neoplasms
The New England Journal of Medicinegeneral

Somatic Mutations of IDH1 and IDH2 in the Leukemic Transformation of Myeloproliferative Neoplasms

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1YdktUYmluU2p4SEluNTBkZF9oNWhWeGY0LVdDNkprWW9HR1Z6RHc3Vk5zV1pVRTQxX0tQUWIxUjR4UWV5MUdfNVNoQWxYLXRuZy1qVVhVbmJWbHFqS1M4?oc=5" target="_blank">Somatic Mutations of IDH1 and IDH2 in the Leukemic Transformation of Myeloproliferative Neoplasms</a>  <font color="#6f6f6f">The New England Journal of Medicine</font>

Read Full StoryMore like this
Targeted Treatment May Improve Outcomes in IDH1-Mutated MDS
The American Journal of Managed Caregeneral

Targeted Treatment May Improve Outcomes in IDH1-Mutated MDS

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOV3RTLXJNbm5YYmpSaHdJbEY0MkxsRmlrdEtUVUNwbzJTekNrQW9SOUlSd1hTRnJTVXZwc0hKcEFiMEctRmItVzJybjUzWDY0ckhyM05sdjdoZ2xObXNtWXljeTJ3NWpqWXYyWWVjVVJUc2ttQ0xZamJrZUtGeXZCWnFOOE02dnp5SHlzUzN0TC1NUQ?oc=5" target="_blank">Targeted Treatment May Improve Outcomes in IDH1-Mutated MDS</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Read Full StoryMore like this
Clonal hematopoiesis and its progression to myeloid neoplasms: insights into risk, biology, and therapeutic strategies
Haematologicageneral

Clonal hematopoiesis and its progression to myeloid neoplasms: insights into risk, biology, and therapeutic strategies

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE0wVGJmZkcyVk5fbllOeFJtLWFZTVhuSUVWZjA2UFJEV2ZOTVBxSzR0Y2RNVTQzYS1wbm9veUpsekZfQ2FMYnJfMjk1Wk5EUEIwa3FocFZCbw?oc=5" target="_blank">Clonal hematopoiesis and its progression to myeloid neoplasms: insights into risk, biology, and therapeutic strategies</a>  <font color="#6f6f6f">Haematologica</font>

Read Full StoryMore like this
IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
Science | AAASgeneral

IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9uZ0JXendPRWFGTk9RbTFOMlk0YWpBYWhNRXcyR0x3a2dNSzBGY3ctLWtOYUlJMUNiUFhIZFZIdkZUSUpRenlDclYwYzctak9yTDdjQ3V5SEFxUVRPTXRVcw?oc=5" target="_blank">IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation</a>  <font color="#6f6f6f">Science | AAAS</font>

Read Full StoryMore like this
Molecular and clinical characteristics of IDH mutations in Chinese NSCLC patients and potential treatment strategies
Wiley Online Librarygeneral

Molecular and clinical characteristics of IDH mutations in Chinese NSCLC patients and potential treatment strategies

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBIMVQ0U21fSHlsNG1GOXY5UnMzemNNb2hPcktGVkx1UWFLSHRGbTNHajJoZHRRZGQtcWJJdy14cFVCVEpiS1htMS1tcGRkYVYycTlNUS1pM2FkYWNVX1VabUVLNEJlSFlVeHc?oc=5" target="_blank">Molecular and clinical characteristics of IDH mutations in Chinese NSCLC patients and potential treatment strategies</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
Rare IDH hotspot mutations in dysembryoplastic neuroepithelial tumors expand the spectrum of IDH-altered CNS tumors
Springer Nature Linkgeneral

Rare IDH hotspot mutations in dysembryoplastic neuroepithelial tumors expand the spectrum of IDH-altered CNS tumors

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBUSlBpdmxBQ3ptbDVNSDBaUmVQWFRSQkFfWG9ycVdTNFBKWTczZFZkblBsNWtIdlRvNW5MY0dKblcybUkzZmM0UlVJMTMwUkxqbTJnZ1J0RngyUVpROU9ocmlzMkYtNjhhY01xQg?oc=5" target="_blank">Rare IDH hotspot mutations in dysembryoplastic neuroepithelial tumors expand the spectrum of IDH-altered CNS tumors</a>  <font color="#6f6f6f">Springer Nature Link</font>

Read Full StoryMore like this
Differentiation therapy for IDH1/2 mutant malignancies
Naturegeneral

Differentiation therapy for IDH1/2 mutant malignancies

<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTFBXQ0VtWU9rVFcwT0xSWFhqMFJOSXVxYXpZejU1Qzd3Z3hkWUtEWjFtUzAxWDVuN0NmWklNNTZqOXpEb0d1eDVRWVNtUEp1VG05dHc?oc=5" target="_blank">Differentiation therapy for IDH1/2 mutant malignancies</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
IDH1 and IDH2 Mutations in Gliomas
NEJMgeneral

IDH1 and IDH2 Mutations in Gliomas

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBpM3F0blhlR29WcDVFR2pkNy1Ia2FSaExnN0RfZnBQLWlBOUJXRXdCMTM5ZHlnalZyelJvU0JOTXgyMlMzdzQzb2RfUHZfcW9KRkZhQW5UMkZrSGo1TU5HMw?oc=5" target="_blank">IDH1 and IDH2 Mutations in Gliomas</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Pathogenesis and management of high molecular risk myeloproliferative neoplasms
Haematologicageneral

Pathogenesis and management of high molecular risk myeloproliferative neoplasms

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFA5MmN6OHdMdkdDSG9UUzA5b3pMbjJhc0lZODk5ZWNFanhKY0xuSW9GRmtHNFB2YmJVWVlKUUVNNUZYSVF1S05rVXFKZE81Y2RNZ0I3OXVQTQ?oc=5" target="_blank">Pathogenesis and management of high molecular risk myeloproliferative neoplasms</a>  <font color="#6f6f6f">Haematologica</font>

Read Full StoryMore like this
What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias?
Natureworld

What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias?

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5qd0VJdk1FV3dpMzNJNFd3aUlWUHdzU2lSbl9qbGxaX09Qd01XZG5sME9haTFab2hEblJFWnVSV0oxRURkWWFSZ3VHay1CU0YyU1VVaVVRQS12RlRXaURj?oc=5" target="_blank">What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias?</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers
Natureworld

Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1DeWlpTzlxdXRMaVFfRnk3XzJaU18tZGNtYnBCWXVjUzJmOXlNSzRrMmViM0dWOWQ4RWJhcHJITVh3WjJURUk1eEZFSHQwNEVwX0psVHp2aXgyZlN3LXM0?oc=5" target="_blank">Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia
Naturegeneral

Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1odE44aXJ3OGxRSmY1eXJXbExuRHpnNEw4QnVIdlR4SDVBX25KQzA0aWJmbEZyaC1rMmdYd1puMEtNVDFtdHROMDFqYzVqcVg4SEdJQXZrV3UzUWpMSFdR?oc=5" target="_blank">Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia | Blood Cancer Journal
Naturegeneral

Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE10U1U2cnRzVWxBWXgxTnpBU2lNUk16bXN1enRDVUVveThkMG9QcE5rWjZ5ZUVvSzQ2STlyelZGb1hYR21xMmVySUdlR21xeEpja2VhazJYZ1hpR3hqTFpJ?oc=5" target="_blank">Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
Naturegeneral

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9BX0R1MTdvVTNSeFBuV0dLaVNsZ29BUlVObk9RTTNwdkJROGR3SDN2b3dOMEV4X3VGX3k5aERrUEhscXJoTjUtbERPNlhzSllmSDRJbnBJUGJ5LWVjMmk4?oc=5" target="_blank">Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Isocitrate dehydrogenase mutations in myeloid malignancies - Leukemia
Naturegeneral

Isocitrate dehydrogenase mutations in myeloid malignancies - Leukemia

<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE01YzdhaUhzOVljbmVVQ2p5d0JZcTlrUGdhTDZCNV9MSC11TlJaNzJRUF9oSGFZSmtyLS1tS0I3ZkNXVk95dllSdmhRNU4zZk5OOGI3TQ?oc=5" target="_blank">Isocitrate dehydrogenase mutations in myeloid malignancies - Leukemia</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2
Naturegeneral

In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1tVmJGQnlJeFk0cXFYWWlvbE9Ub2ZZMFRlQ3dwTzdLTk1tdDgzaWlHeUowbVlFSkM3WXlyZHBGaHBXQVMtS1lMbUdpdzBsaTV0TDZtLTFycWpPT3MxTklr?oc=5" target="_blank">In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1 -mutated chondrosarcoma: phase 1b/2 trial
Naturegeneral

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1 -mutated chondrosarcoma: phase 1b/2 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE94NS1jWmx5dFduYk1Lb2pzemVPamF5Rk9qeENkekYwSU0xVjZvNVMyX2xmMXlHRnVUZDFJZHdBWjVyd0tNb1pnWHk5N3JhWUE2LTFCSXRzRDk0ZDRyNHRj?oc=5" target="_blank">Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1 -mutated chondrosarcoma: phase 1b/2 trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A molecular signature predicts hematologic evolution in polycythemia vera patients | Leukemia
Naturegeneral

A molecular signature predicts hematologic evolution in polycythemia vera patients | Leukemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1STjJlYjZPdm1UVFNGTFNRLWVHWmF1aWxlTllvZTBzekhmMkhlS2xLSWtvRFFVcEpvWHJqZGZ6UDc4d3d1aFhKMExoVkVFZENNdXI5bEFWbFlyNjVLOFNn?oc=5" target="_blank">A molecular signature predicts hematologic evolution in polycythemia vera patients | Leukemia</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants
Natureworld

A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBwUzFYUDJMRjhyUmNqcW9VejUtQU9aSVBreE1meVBDakdTcVpoZVZZTFZrWHpaOWxvMEFmeDJKYUs3UnVnSDBMd3FaUkZrRG5JVmVaQm5QNGIyR2N0bWZv?oc=5" target="_blank">A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
High Molecular Risk Mutations Assessed for Prognostic Scoring Systems for Primary Myelofibrosis
Hematology Advisorgeneral

High Molecular Risk Mutations Assessed for Prognostic Scoring Systems for Primary Myelofibrosis

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPb0FTTDRkZm10b1VuSHhwNWRsV0tLLWlsRmxJc2VxbVB0LUtkaXNnVTlUXy1TWW9DSGQ2cUJHa09wQVFlNzdkOG11TFdfYTdSb0V0eVJfcXRXalRoODJKZmRYLUY3Wmh6NmQtdDZMYlhtZkpJOVdpd3RiSldYeDJ5MWtDRUxmbnlDalBmRGFUUV92MFRFWmRXSlE4SmhQcWxJUngxNmtydE9xbnRLOTBQcmw0eXM?oc=5" target="_blank">High Molecular Risk Mutations Assessed for Prognostic Scoring Systems for Primary Myelofibrosis</a>  <font color="#6f6f6f">Hematology Advisor</font>

Read Full StoryMore like this
Candidate gene mutations of patients with astrocytoma who present with seizures: evidence from whole exome sequencing
Frontiersgeneral

Candidate gene mutations of patients with astrocytoma who present with seizures: evidence from whole exome sequencing

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPbmg5NW5mX0tkVlN1VlU1LW9OemNmZFpFbWwtMzNrYWh3T2p5U1VQNU1PQkFNdXo2SVBpdWFOMEZfOXhvOWczblEwMVhrMHpvbEVESUV6aE1fMnhmLTVOc3JkTk5OU25IekU0V3pUczNvSW1BWXo2NnJrSS15VjVFU0VLSE9jZi1GOUZ0NUh3?oc=5" target="_blank">Candidate gene mutations of patients with astrocytoma who present with seizures: evidence from whole exome sequencing</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
NEJMworld

Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1MSG1HdDBBZTdfRmxfZ2ZvQ1kzSzhNQkpkTV9IbnVlR2puSWU2MnpUZzBaN2I0WWNDRlZmUXgzY0NiRF9qOTI0V2s0VTNmbHdVVlNhUThhRWVDODZ5YTBOaA?oc=5" target="_blank">Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets
Frontiersworld

Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNV1FxYTNTalpqcTd1ek9iT250ejBSUXlTRDFfZ3VWRS1KWnZJMHFhdW8xMkQ1VW50cFZuS0Q1YkFPcFUzWUNEbHFRZFpYY25uT3dBRHNIMnhJNDFqUERsS3hIb2lfX0pobm5kRTkyS1RVdHdpeVJld2hMU1M2QXI1VlduM0xrcXlsNXBLUEJTMGxyZw?oc=5" target="_blank">Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
Frontierstech

The genetics of myelodysplastic syndromes and the opportunities for tailored treatments

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOWjQwbmVFenhvazBMd0c0Z1VBMEt1Sl9nWWRyRmdMdTBaT2dtMVgzbGczN3locGpodWhQc2g1TW1kcTNwM3ZuZVF3MXZFT2JKLVdDQ242dzU1akhmN1p0ZHJCc0pGRExRRU1lNGtyRklnbl95YzkyZ2xtRTgyMWFhNXV1WmQ0Wm9BOGhwcA?oc=5" target="_blank">The genetics of myelodysplastic syndromes and the opportunities for tailored treatments</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Using somatic variant richness to mine signals from rare variants in the cancer genome
Naturegeneral

Using somatic variant richness to mine signals from rare variants in the cancer genome

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9NdFlTZHg5MmxQR0h5WWp4WFNJWHNfN2ZqR2xTWlEza1RfRG93Zm9HQ2NhTmNTRUlpUERDTkZRRU4zOUh4cWxVUW8tem9nVm5sTmRDaThBR3VNVUFtY1k0?oc=5" target="_blank">Using somatic variant richness to mine signals from rare variants in the cancer genome</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver
Naturegeneral

Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBjM2t6MVN4LW1FX1hUUklHTmhob01NSkVzLVhnV2p4RGNyVWc3ZC1lbnROcVo0RjlfbUpvNVpMTkdIQkl6UDFSbzVWeXd6U1pVTlhIQlRFY3JrRExPc2R3?oc=5" target="_blank">Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH
Naturegeneral

D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH

<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE5fREVtNVpyOGhKVzlJNEExMUVzMk54c0pfd0NmVmdBMDR5MVItZ19RY3JWMXFMZHlTQVZmazZhcjlEUnh2d3ZFZ1k2d1dDNjdQVW84bjVR?oc=5" target="_blank">D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial | Blood Cancer Journal
Naturegeneral

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0zTnB1NE14dGxoNzBXTHc2MnQ2bEVGLWVnZE9WckM4U1o2ZWp3b1pkdkNHOVAySzhBcDFXRGVEVEtmZk1UdGlpZEZVYzdFYUhMcmFKUm5XNHI3X1dDeHhN?oc=5" target="_blank">Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
"IDH1/2 Somatic Mutations:" — Live Google News Trends & Headlines